@article{article, title  = {{Efficacy, pharmacodynamics, pharmacokinetics, safety, and immunogenicity of Bmab 1000 versus reference denosumab: 78-wk results from a randomized, double-blind, multicenter, parallel-arm phase 3 trial (DEVOTE) in women with postmenopausal osteoporosis}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{https://doi.org/10.1093/jbmrpl/ziag062 }},

 year = {{2026}},

 month = {{4}},

 author = {{Eastell R and Orwoll E and Cosman F and Plebanski R and Kumar K and Marwah A and Deodhar SS and Wolff-Holz E and Loganathan S}},

 doi = {{10.1093/jbmrpl/ziag062}},

 journal = {{JBMR Plus}},

 note = {{Accessed on 2026/04/26}}}